Alpha-antitrypsin Deficiency Treatment Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of Alpha-antitrypsin Deficiency Treatment Market

1.3 Market Segment by Type

1.3.1 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of CT-2009 from 2016 to 2027

1.3.2 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of POL-6014 from 2016 to 2027

1.3.3 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of ARO-AAT from 2016 to 2027

1.3.4 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of ALNAAT-02 from 2016 to 2027

1.3.5 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic from 2016 to 2027

1.4.2 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital from 2016 to 2027

1.4.3 China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of Alpha-antitrypsin Deficiency Treatment by Major Types

3.4.1 Market Size and Growth Rate of CT-2009

3.4.2 Market Size and Growth Rate of POL-6014

3.4.3 Market Size and Growth Rate of ARO-AAT

3.4.4 Market Size and Growth Rate of ALNAAT-02

3.4.5 Market Size and Growth Rate of Others

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of Alpha-antitrypsin Deficiency Treatment by Major End-Users

4.4.1 Market Size and Growth Rate of Alpha-antitrypsin Deficiency Treatment in Clinic

4.4.2 Market Size and Growth Rate of Alpha-antitrypsin Deficiency Treatment in Hospital

4.4.3 Market Size and Growth Rate of Alpha-antitrypsin Deficiency Treatment in Others

5.1 China Alpha-antitrypsin Deficiency Treatment Production Analysis by Regions

5.2 China Alpha-antitrypsin Deficiency Treatment Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

6.2 North China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

7.1 Central China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

7.2 Central China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

8.1 South China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

8.2 South China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

9.1 East China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

9.2 East China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

10.1 Northeast China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

10.2 Northeast China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

11.1 Southwest China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

11.2 Southwest China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

12.1 Northwest China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major Types

12.2 Northwest China Alpha-antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users

13.1 Dicerna Pharmaceuticals, Inc

13.2 International Stem Cell Corporation

13.3 Arrowhead Pharmaceuticals, Inc

13.4 Alnylam Pharmaceuticals, Inc

13.5 Adverum Biotechnologies, Inc

13.6 Inhibrx

13.7 ProMetic Life Sciences Inc

13.8 Digna Biotech, SL

13.9 Sangamo BioSciences, Inc

13.10 Carolus Therapeutics, Inc

13.11 Intellia Therapeutics, Inc

13.12 Grifols, SA

13.13 Ionis Pharmaceuticals, Inc

13.14 Kamada Ltd

13.15 Applied Genetic Technologies Corporation

13.16 Editas Medicine, Inc

13.17 Polyphor Ltd

13.18 Cevec Pharmaceuticals GmbH

13.19 rEVO Biologics, Inc

Figure Product Picture

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of CT-2009 from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of POL-6014 from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of ARO-AAT from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of ALNAAT-02 from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital from 2016 to 2027

Figure China Alpha-antitrypsin Deficiency Treatment Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of Alpha-antitrypsin Deficiency Treatment Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of Alpha-antitrypsin Deficiency Treatment

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of Alpha-antitrypsin Deficiency Treatment by Different Types from 2016 to 2027

Table Consumption Share of Alpha-antitrypsin Deficiency Treatment by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of CT-2009

Figure Market Size and Growth Rate of POL-6014

Figure Market Size and Growth Rate of ARO-AAT

Figure Market Size and Growth Rate of ALNAAT-02

Figure Market Size and Growth Rate of Others

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of Alpha-antitrypsin Deficiency Treatment by Different End-Users from 2016 to 2027

Table Consumption Share of Alpha-antitrypsin Deficiency Treatment by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Clinic

Figure Market Size and Growth Rate of Hospital

Figure Market Size and Growth Rate of Others

Table China Alpha-antitrypsin Deficiency Treatment Production by Regions

Table China Alpha-antitrypsin Deficiency Treatment Production Share by Regions

Figure China Alpha-antitrypsin Deficiency Treatment Production Share by Regions in 2016

Figure China Alpha-antitrypsin Deficiency Treatment Production Share by Regions in 2021

Figure China Alpha-antitrypsin Deficiency Treatment Production Share by Regions in 2027

Table China Alpha-antitrypsin Deficiency Treatment Consumption by Regions

Table China Alpha-antitrypsin Deficiency Treatment Consumption Share by Regions

Figure China Alpha-antitrypsin Deficiency Treatment Consumption Share by Regions in 2016

Figure China Alpha-antitrypsin Deficiency Treatment Consumption Share by Regions in 2021

Figure China Alpha-antitrypsin Deficiency Treatment Consumption Share by Regions in 2027

Table North China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table North China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table North China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table North China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure North China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table Central China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table Central China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure Central China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table South China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table South China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table South China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table South China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure South China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table East China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table East China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table East China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table East China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure East China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table Northeast China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table Northeast China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure Northeast China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table Southwest China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table Southwest China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure Southwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table Northwest China Alpha-antitrypsin Deficiency Treatment Consumption by Types from 2016 to 2027

Table Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types from 2016 to 2027

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2016

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2021

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by Types in 2027

Table Northwest China Alpha-antitrypsin Deficiency Treatment Consumption by End-Users from 2016 to 2027

Table Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users from 2016 to 2027

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2016

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2021

Figure Northwest China Alpha-antitrypsin Deficiency Treatment Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Dicerna Pharmaceuticals, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals, Inc

Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals, Inc

Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals, Inc

Table Product and Service Introduction of Dicerna Pharmaceuticals, Inc

Table Company Profile and Development Status of International Stem Cell Corporation

Table Sales, Revenue, Sales Price and Gross Margin Analysis of International Stem Cell Corporation

Figure Sales and Growth Rate Analysis of International Stem Cell Corporation

Figure Revenue and Market Share Analysis of International Stem Cell Corporation

Table Product and Service Introduction of International Stem Cell Corporation

Table Company Profile and Development Status of Arrowhead Pharmaceuticals, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Pharmaceuticals, Inc

Figure Sales and Growth Rate Analysis of Arrowhead Pharmaceuticals, Inc

Figure Revenue and Market Share Analysis of Arrowhead Pharmaceuticals, Inc

Table Product and Service Introduction of Arrowhead Pharmaceuticals, Inc

Table Company Profile and Development Status of Alnylam Pharmaceuticals, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals, Inc

Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals, Inc

Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals, Inc

Table Product and Service Introduction of Alnylam Pharmaceuticals, Inc

Table Company Profile and Development Status of Adverum Biotechnologies, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adverum Biotechnologies, Inc

Figure Sales and Growth Rate Analysis of Adverum Biotechnologies, Inc

Figure Revenue and Market Share Analysis of Adverum Biotechnologies, Inc

Table Product and Service Introduction of Adverum Biotechnologies, Inc

Table Company Profile and Development Status of Inhibrx

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inhibrx

Figure Sales and Growth Rate Analysis of Inhibrx

Figure Revenue and Market Share Analysis of Inhibrx

Table Product and Service Introduction of Inhibrx

Table Company Profile and Development Status of ProMetic Life Sciences Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProMetic Life Sciences Inc

Figure Sales and Growth Rate Analysis of ProMetic Life Sciences Inc

Figure Revenue and Market Share Analysis of ProMetic Life Sciences Inc

Table Product and Service Introduction of ProMetic Life Sciences Inc

Table Company Profile and Development Status of Digna Biotech, SL

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Digna Biotech, SL

Figure Sales and Growth Rate Analysis of Digna Biotech, SL

Figure Revenue and Market Share Analysis of Digna Biotech, SL

Table Product and Service Introduction of Digna Biotech, SL

Table Company Profile and Development Status of Sangamo BioSciences, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo BioSciences, Inc

Figure Sales and Growth Rate Analysis of Sangamo BioSciences, Inc

Figure Revenue and Market Share Analysis of Sangamo BioSciences, Inc

Table Product and Service Introduction of Sangamo BioSciences, Inc

Table Company Profile and Development Status of Carolus Therapeutics, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Carolus Therapeutics, Inc

Figure Sales and Growth Rate Analysis of Carolus Therapeutics, Inc

Figure Revenue and Market Share Analysis of Carolus Therapeutics, Inc

Table Product and Service Introduction of Carolus Therapeutics, Inc

Table Company Profile and Development Status of Intellia Therapeutics, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics, Inc

Figure Sales and Growth Rate Analysis of Intellia Therapeutics, Inc

Figure Revenue and Market Share Analysis of Intellia Therapeutics, Inc

Table Product and Service Introduction of Intellia Therapeutics, Inc

Table Company Profile and Development Status of Grifols, SA

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols, SA

Figure Sales and Growth Rate Analysis of Grifols, SA

Figure Revenue and Market Share Analysis of Grifols, SA

Table Product and Service Introduction of Grifols, SA

Table Company Profile and Development Status of Ionis Pharmaceuticals, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals, Inc

Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals, Inc

Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals, Inc

Table Product and Service Introduction of Ionis Pharmaceuticals, Inc

Table Company Profile and Development Status of Kamada Ltd

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada Ltd

Figure Sales and Growth Rate Analysis of Kamada Ltd

Figure Revenue and Market Share Analysis of Kamada Ltd

Table Product and Service Introduction of Kamada Ltd

Table Company Profile and Development Status of Applied Genetic Technologies Corporation

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Applied Genetic Technologies Corporation

Figure Sales and Growth Rate Analysis of Applied Genetic Technologies Corporation

Figure Revenue and Market Share Analysis of Applied Genetic Technologies Corporation

Table Product and Service Introduction of Applied Genetic Technologies Corporation

Table Company Profile and Development Status of Editas Medicine, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine, Inc

Figure Sales and Growth Rate Analysis of Editas Medicine, Inc

Figure Revenue and Market Share Analysis of Editas Medicine, Inc

Table Product and Service Introduction of Editas Medicine, Inc

Table Company Profile and Development Status of Polyphor Ltd

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Polyphor Ltd

Figure Sales and Growth Rate Analysis of Polyphor Ltd

Figure Revenue and Market Share Analysis of Polyphor Ltd

Table Product and Service Introduction of Polyphor Ltd

Table Company Profile and Development Status of Cevec Pharmaceuticals GmbH

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cevec Pharmaceuticals GmbH

Figure Sales and Growth Rate Analysis of Cevec Pharmaceuticals GmbH

Figure Revenue and Market Share Analysis of Cevec Pharmaceuticals GmbH

Table Product and Service Introduction of Cevec Pharmaceuticals GmbH

Table Company Profile and Development Status of rEVO Biologics, Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of rEVO Biologics, Inc

Figure Sales and Growth Rate Analysis of rEVO Biologics, Inc

Figure Revenue and Market Share Analysis of rEVO Biologics, Inc

Table Product and Service Introduction of rEVO Biologics, Inc